Recent disappointing results for ventricular assist device companies are raising questions over adoption of the technology—which is meant to assist patients’ weakened hearts with pumping blood. HeartMate II, as shown on ...
The US Food and Drug Administration (FDA) has approved Thoratec's HeartMate II Pocket Controller, the safe face of the HeartMate II LVAD System. The Pocket Controller is lighter and compact than the previous LVAD system controllers, and ...
Thoratec has gained an investigational device exemption(IDE)from the US Food and Drug Administration(FDA)for the initiation of a feasibility clinical study of its continuous-flow left ventricular assist device(LVAD),for the treatment of ...
Cleveland Heart, a joint venture between Cleveland Clinic and TransWorld Medical Devices, has obtained $30m grant from Power Heart Consortium to develop its SmartHeart, continue international clinical trials, expand laboratory research and ...
Tags: clinic development, LVAD, investment